ENDRA Life Sciences Announces Pricing of Upsized $4.5M Public Offering Of 3.75M Shares Of Common Stock And Warrants To Purchase 1.875M Shares Of Common Stock
ENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today that it has priced an underwritten public